bioMerieux (FR:BIM) has released an update.
bioMérieux reports robust performance in the first nine months of 2024, with a 10.3% organic sales growth driven by the success of its GO•28 strategic plan. Key growth areas include BIOFIRE® panels and SPOTFIRE® solutions, with significant contributions from microbiology and industrial applications. The company remains optimistic about achieving its revised full-year targets despite currency challenges.
For further insights into FR:BIM stock, check out TipRanks’ Stock Analysis page.
